1. Home
  2. ARDX
  3. ARDX News

Latest Ardelyx Inc. (ARDX) News on April 3, 2025

Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings
ARDX

GlobeNewswire

2 days ago

Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings

Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award
ARDX

GlobeNewswire

21 days ago

Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award

High Growth Tech Stocks In The US With Promising Potential
ARDX

Simply Wall St.

23 days ago

High Growth Tech Stocks In The US With Promising Potential

ARDX

MT Newswires

a month ago

BTIG Initiates Ardelyx at Buy With $14 Price Target

ARDX

Argus Research

a month ago

Daily – Vickers Top Buyers & Sellers for 02/27/2025

Ardelyx Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
ARDX

Simply Wall St.

a month ago

Ardelyx Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

ARDX

MT Newswires

a month ago

Ardelyx Says China Approves New Drug Application for Hyperphosphatemia Treatment Tenapanor; Shares Up Pre-Bell

Tenapanor Approved in China for Hyperphosphatemia
ARDX

GlobeNewswire

a month ago

Tenapanor Approved in China for Hyperphosphatemia

Ardelyx to Participate in Upcoming Investor Conferences
ARDX

GlobeNewswire

a month ago

Ardelyx to Participate in Upcoming Investor Conferences

Institutional investors may adopt severe steps after Ardelyx, Inc.'s (NASDAQ:ARDX) latest 11% drop adds to a year losses
ARDX

Simply Wall St.

a month ago

Institutional investors may adopt severe steps after Ardelyx, Inc.'s (NASDAQ:ARDX) latest 11% drop adds to a year losses

Ardelyx Inc (ARDX) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Challenges
ARDX

GuruFocus.com

a month ago

Ardelyx Inc (ARDX) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Challenges

ARDX

Thomson Reuters StreetEvents

a month ago

Q4 2024 Ardelyx Inc Earnings Call

Ardelyx (ARDX) Reports Q4 Earnings: What Key Metrics Have to Say
ARDX

Zacks

a month ago

Ardelyx (ARDX) Reports Q4 Earnings: What Key Metrics Have to Say

Ardelyx (ARDX) Meets Q4 Earnings Estimates
ARDX

Zacks

a month ago

Ardelyx (ARDX) Meets Q4 Earnings Estimates

ARDX

MT Newswires

a month ago

Ardelyx Swings to Q4 Earnings, Revenue Rises

ARDX

Associated Press Finance

a month ago

Ardelyx: Q4 Earnings Snapshot

Ardelyx Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
ARDX

GlobeNewswire

a month ago

Ardelyx Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Ardelyx to Present at the TD Cowen 45th Annual Health Care Conference
ARDX

GlobeNewswire

a month ago

Ardelyx to Present at the TD Cowen 45th Annual Health Care Conference

BioCryst Pharmaceuticals (BCRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
ARDX

Zacks

a month ago

BioCryst Pharmaceuticals (BCRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Ardelyx (ARDX) Earnings Expected to Grow: Should You Buy?
ARDX

Zacks

2 months ago

Ardelyx (ARDX) Earnings Expected to Grow: Should You Buy?

Ardelyx to Report Full Year and Fourth Quarter 2024 Financial Results on February 20, 2025
ARDX

GlobeNewswire

2 months ago

Ardelyx to Report Full Year and Fourth Quarter 2024 Financial Results on February 20, 2025

High Growth Tech Stocks To Watch In January 2025
ARDX

Simply Wall St.

2 months ago

High Growth Tech Stocks To Watch In January 2025

Chairman David Mott Bets $1M on Ardelyx--Is This Biotech Stock Set to Skyrocket?
ARDX

GuruFocus.com

2 months ago

Chairman David Mott Bets $1M on Ardelyx--Is This Biotech Stock Set to Skyrocket?

ARDX

Argus Research

2 months ago

Daily – Vickers Top Buyers & Sellers for 01/23/2025

Ardelyx (ARDX) Moves 16.0% Higher: Will This Strength Last?
ARDX

Zacks

3 months ago

Ardelyx (ARDX) Moves 16.0% Higher: Will This Strength Last?

Ardelyx Provides Update on Increasing Commercial Momentum and 2025 Strategic Priorities
ARDX

GlobeNewswire

3 months ago

Ardelyx Provides Update on Increasing Commercial Momentum and 2025 Strategic Priorities

Ardelyx to Present at the 43rd Annual J.P. Morgan Healthcare Conference
ARDX

GlobeNewswire

3 months ago

Ardelyx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Why Ardelyx (ARDX) Is One of the Best Biotech Penny Stocks to Invest in Now?
ARDX

Insider Monkey

3 months ago

Why Ardelyx (ARDX) Is One of the Best Biotech Penny Stocks to Invest in Now?

Exploring 3 High Growth Tech Stocks in the United States
ARDX

Simply Wall St.

3 months ago

Exploring 3 High Growth Tech Stocks in the United States

US Penny Stocks To Watch In December 2024
ARDX

Simply Wall St.

3 months ago

US Penny Stocks To Watch In December 2024

ARDX

Argus Research

3 months ago

Daily – Vickers Top Buyers & Sellers for 12/27/2024

ARDX

Argus Research

3 months ago

Daily – Vickers Top Buyers & Sellers for 12/26/2024

ARDX

Argus Research

3 months ago

Daily – Vickers Top Buyers & Sellers for 12/24/2024

ARDX

MT Newswires

3 months ago

Ardelyx Insider Bought Shares Worth $996,580, According to a Recent SEC Filing

Ardelyx, Inc. (NASDAQ:ARDX): Is Breakeven Near?
ARDX

Simply Wall St.

4 months ago

Ardelyx, Inc. (NASDAQ:ARDX): Is Breakeven Near?

Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference
ARDX

GlobeNewswire

4 months ago

Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference

High Growth Tech Stocks To Explore In November 2024
ARDX

Simply Wall St.

4 months ago

High Growth Tech Stocks To Explore In November 2024

US Penny Stocks To Monitor In November 2024
ARDX

Simply Wall St.

5 months ago

US Penny Stocks To Monitor In November 2024

ARDX

Argus Research

5 months ago

Daily – Vickers Top Buyers & Sellers for 11/15/2024

ARDX

MT Newswires

5 months ago

Ardelyx Insider Bought Shares Worth $996,598, According to a Recent SEC Filing

ARDX

MT Newswires

5 months ago

HC Wainwright Downgrades Ardelyx to Neutral From Buy, Adjusts Price Target to $5.50 From $11.50

ARDX

MT Newswires

5 months ago

Ardelyx Shares Fall After Federal Judge Dismisses Lawsuit Against CMS

Ardelyx Responds to District Court Decision Granting Motion to Dismiss
ARDX

GlobeNewswire

5 months ago

Ardelyx Responds to District Court Decision Granting Motion to Dismiss

Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference
ARDX

GlobeNewswire

5 months ago

Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference

Ardelyx Third Quarter 2024 Earnings: US$0.003 loss per share (vs US$0.03 profit in 3Q 2023)
ARDX

Simply Wall St.

5 months ago

Ardelyx Third Quarter 2024 Earnings: US$0.003 loss per share (vs US$0.03 profit in 3Q 2023)

ARDX

Thomson Reuters StreetEvents

5 months ago

Q3 2024 Ardelyx Inc Earnings Call

ARDX

MT Newswires

5 months ago

Ardelyx Posts Breakeven Q3 Earnings, Revenue Increases

Ardelyx Inc (ARDX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Amidst ...
ARDX

GuruFocus.com

5 months ago

Ardelyx Inc (ARDX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Amidst ...

Compared to Estimates, Ardelyx (ARDX) Q3 Earnings: A Look at Key Metrics
ARDX

Zacks

5 months ago

Compared to Estimates, Ardelyx (ARDX) Q3 Earnings: A Look at Key Metrics

Ardelyx (ARDX) Reports Break-Even Earnings for Q3
ARDX

Zacks

5 months ago

Ardelyx (ARDX) Reports Break-Even Earnings for Q3

ARDX

Associated Press Finance

5 months ago

Ardelyx: Q3 Earnings Snapshot

Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update
ARDX

GlobeNewswire

5 months ago

Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update

Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology’s (ACG) Annual Meeting
ARDX

GlobeNewswire

5 months ago

Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology’s (ACG) Annual Meeting

Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth
ARDX

Zacks

5 months ago

Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth

Ardelyx Shares Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) at the American Society of Nephrology’s Kidney Week
ARDX

GlobeNewswire

5 months ago

Ardelyx Shares Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) at the American Society of Nephrology’s Kidney Week

Earnings Preview: Ardelyx (ARDX) Q3 Earnings Expected to Decline
ARDX

Zacks

5 months ago

Earnings Preview: Ardelyx (ARDX) Q3 Earnings Expected to Decline

Ardelyx Announces Launch of Gut Matters: Discoveries and Innovations, a New Podcast for the IBS-C Patient Community
ARDX

GlobeNewswire

5 months ago

Ardelyx Announces Launch of Gut Matters: Discoveries and Innovations, a New Podcast for the IBS-C Patient Community

Ardelyx Announces the Derek Forfang Patient Advocate Award to Recognize Advocates for the Chronic Kidney Disease Community
ARDX

GlobeNewswire

5 months ago

Ardelyx Announces the Derek Forfang Patient Advocate Award to Recognize Advocates for the Chronic Kidney Disease Community

Here's Why Ardelyx (ARDX) Could be Great Choice for a Bottom Fisher
ARDX

Zacks

6 months ago

Here's Why Ardelyx (ARDX) Could be Great Choice for a Bottom Fisher

Ardelyx to Report Third Quarter 2024 Financial Results on October 31, 2024
ARDX

GlobeNewswire

6 months ago

Ardelyx to Report Third Quarter 2024 Financial Results on October 31, 2024

Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the American Society of Nephrology’s Kidney Week
ARDX

GlobeNewswire

6 months ago

Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the American Society of Nephrology’s Kidney Week

Ardelyx Inc (ARDX) Q2 2024 Earnings Call Highlights: Revenue Surge and Strategic Challenges
ARDX

GuruFocus.com

6 months ago

Ardelyx Inc (ARDX) Q2 2024 Earnings Call Highlights: Revenue Surge and Strategic Challenges

Even though Ardelyx (NASDAQ:ARDX) has lost US$210m market cap in last 7 days, shareholders are still up 352% over 3 years
ARDX

Simply Wall St.

6 months ago

Even though Ardelyx (NASDAQ:ARDX) has lost US$210m market cap in last 7 days, shareholders are still up 352% over 3 years

Ardelyx Announces Publication of a Review Article Exploring the Patient Burden and Therapeutic Landscape of IBS-C in the U.S. in Clinical and Experimental Gastroenterology
ARDX

GlobeNewswire

6 months ago

Ardelyx Announces Publication of a Review Article Exploring the Patient Burden and Therapeutic Landscape of IBS-C in the U.S. in Clinical and Experimental Gastroenterology

Wall Street Analysts Think Ardelyx (ARDX) Could Surge 65.4%: Read This Before Placing a Bet
ARDX

Zacks

6 months ago

Wall Street Analysts Think Ardelyx (ARDX) Could Surge 65.4%: Read This Before Placing a Bet

ARDX

MT Newswires

6 months ago

Ardelyx Insider Sold Shares Worth $342,983, According to a Recent SEC Filing

Top High Growth Tech Stocks to Watch in September 2024
ARDX

Simply Wall St.

7 months ago

Top High Growth Tech Stocks to Watch in September 2024

Ardelyx to Participate at the 2024 Cantor Global Healthcare Conference
ARDX

GlobeNewswire

7 months ago

Ardelyx to Participate at the 2024 Cantor Global Healthcare Conference

With 62% ownership, Ardelyx, Inc. (NASDAQ:ARDX) boasts of strong institutional backing
ARDX

Simply Wall St.

7 months ago

With 62% ownership, Ardelyx, Inc. (NASDAQ:ARDX) boasts of strong institutional backing

Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
ARDX

GlobeNewswire

8 months ago

Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer

Here's What Key Metrics Tell Us About Ardelyx (ARDX) Q2 Earnings
ARDX

Zacks

8 months ago

Here's What Key Metrics Tell Us About Ardelyx (ARDX) Q2 Earnings

Ardelyx (ARDX) Reports Q2 Loss, Tops Revenue Estimates
ARDX

Zacks

8 months ago

Ardelyx (ARDX) Reports Q2 Loss, Tops Revenue Estimates

ARDX

Associated Press Finance

8 months ago

Ardelyx: Q2 Earnings Snapshot

Ardelyx Reports Second Quarter 2024 Financial Results and Provides Business Update
ARDX

GlobeNewswire

8 months ago

Ardelyx Reports Second Quarter 2024 Financial Results and Provides Business Update

Ardelyx Announces Publication of Two Plain Language Summaries from XPHOZAH® (tenapanor) Clinical Trials in Current Medical Research and Opinion
ARDX

GlobeNewswire

8 months ago

Ardelyx Announces Publication of Two Plain Language Summaries from XPHOZAH® (tenapanor) Clinical Trials in Current Medical Research and Opinion

Will BioCryst Pharmaceuticals (BCRX) Report Negative Earnings Next Week? What You Should Know
ARDX

Zacks

8 months ago

Will BioCryst Pharmaceuticals (BCRX) Report Negative Earnings Next Week? What You Should Know

Ardelyx (ARDX) Expected to Beat Earnings Estimates: Should You Buy?
ARDX

Zacks

8 months ago

Ardelyx (ARDX) Expected to Beat Earnings Estimates: Should You Buy?

Ardelyx sues CMS over revamped kidney disease drug payment bundle
ARDX

Pharmaceutical Technology

8 months ago

Ardelyx sues CMS over revamped kidney disease drug payment bundle

ARDX

MT Newswires

8 months ago

Ardelyx, Groups File Lawsuit Over Dialysis Payment System Coverage

Ardelyx to Report Second Quarter 2024 Financial Results on August 1, 2024
ARDX

GlobeNewswire

9 months ago

Ardelyx to Report Second Quarter 2024 Financial Results on August 1, 2024

Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinically Meaningful Medicines
ARDX

GlobeNewswire

9 months ago

Ardelyx, AAKP and NMQF File Lawsuit to Protect Dialysis Patient Choice and Timely Access to Clinically Meaningful Medicines

Enanta Pharmaceuticals (ENTA) Soars 6.7%: Is Further Upside Left in the Stock?
ARDX

Zacks

9 months ago

Enanta Pharmaceuticals (ENTA) Soars 6.7%: Is Further Upside Left in the Stock?

ARDX

MT Newswires

9 months ago

HC Wainwright Adjusts Ardelyx's Price Target to $10 From $13, Keeps Buy Rating

ARDX

MT Newswires

9 months ago

Wedbush Adjusts Ardelyx's Price Target to $11 From $15, Keeps Outperform Rating

ARDX

MT Newswires

9 months ago

Sector Update: Health Care Stocks Lean Lower Premarket Tuesday

ARDX

MT Newswires

9 months ago

Sector Update: Health Care

ARDX

MT Newswires

9 months ago

Update: Ardelyx Opts Out of CMS Payment Adjustment for Xphozah; Shares Plunge Pre-Bell

ARDX

MT Newswires

9 months ago

Ardelyx Opts Out of CMS Payment Adjustment for Xphozah

To Preserve Patient Access to XPHOZAH®, Ardelyx Chooses Not to File for TDAPA
ARDX

GlobeNewswire

9 months ago

To Preserve Patient Access to XPHOZAH®, Ardelyx Chooses Not to File for TDAPA

Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Healthcare Disciplines
ARDX

GlobeNewswire

9 months ago

Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Healthcare Disciplines

When Will Ardelyx, Inc. (NASDAQ:ARDX) Become Profitable?
ARDX

Simply Wall St.

9 months ago

When Will Ardelyx, Inc. (NASDAQ:ARDX) Become Profitable?

Ardelyx, Inc. Reports Employment Inducement Grants
ARDX

GlobeNewswire

10 months ago

Ardelyx, Inc. Reports Employment Inducement Grants

ARDX

MT Newswires

10 months ago

Ardelyx Shares Fall; Chief Commercial Officer Resigns

Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference
ARDX

GlobeNewswire

10 months ago

Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference

Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults
ARDX

GlobeNewswire

10 months ago

Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults

Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
ARDX

GlobeNewswire

a year ago

Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)

Ardelyx, Inc. Reports Employment Inducement Grants
ARDX

GlobeNewswire

a year ago

Ardelyx, Inc. Reports Employment Inducement Grants

ARDX

MT Newswires

a year ago

Ardelyx Insider Sold Shares Worth $2,522,217, According to a Recent SEC Filing

ARDX

MT Newswires

a year ago

Ardelyx Insider Sold Shares Worth $1,831,503, According to a Recent SEC Filing

ARDX

MT Newswires

a year ago

Ardelyx Insider Sold Shares Worth $333,574, According to a Recent SEC Filing

Share on Social Networks: